NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Authors
Keywords
NAD, metabolism, NAMPT, PD-L1, immune checkpoint blockade, Tet1, epigenetics, interferon γ, cancer immune evasion, cancer immunotherapy
Journal
Cell Metabolism
Volume 33, Issue 1, Pages 110-127.e5
Publisher
Elsevier BV
Online
2020-11-10
DOI
10.1016/j.cmet.2020.10.021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53-suppressed oncogene TET1 prevents cellular aging in lung cancer
- (2019) Piotr T. Filipczak et al. CANCER RESEARCH
- NAD+ metabolism governs the proinflammatory senescence-associated secretome
- (2019) Timothy Nacarelli et al. NATURE CELL BIOLOGY
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
- (2019) Cristina Travelli et al. CANCER RESEARCH
- Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
- (2019) Jiabin Cai et al. GUT
- Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis
- (2019) Kyoko Ito et al. Cell Reports
- Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
- (2018) Mickaël Ohanna et al. GENES & DEVELOPMENT
- Interleukin-10 Directly Inhibits CD8 + T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity
- (2018) Logan K. Smith et al. IMMUNITY
- DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
- (2018) Mehdi Touat et al. JOURNAL OF CLINICAL INVESTIGATION
- Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells
- (2018) Qi Lai et al. ONCOGENE
- α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis
- (2018) Sandra Atlante et al. Cell Death & Disease
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- Immunity drives TET1 regulation in cancer through NF-κB
- (2018) Evelyne Collignon et al. Science Advances
- Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma
- (2018) Jiao Liu et al. HEPATOLOGY
- HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas
- (2018) Qiuyu Lian et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
- (2018) Otília Menyhárt et al. Royal Society Open Science
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia
- (2017) S Takao et al. LEUKEMIA
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity
- (2017) Jing Wang et al. NUCLEIC ACIDS RESEARCH
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- Emerging targets in cancer immunotherapy
- (2017) Samantha Burugu et al. SEMINARS IN CANCER BIOLOGY
- Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
- (2017) Xi Jiang et al. Nature Communications
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine
- (2016) Ambra A Grolla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- What does PD-L1 positive or negative mean?
- (2016) Antoni Ribas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumour hypoxia causes DNA hypermethylation by reducing TET activity
- (2016) Bernard Thienpont et al. NATURE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma
- (2016) Amit D. Gujar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
- (2015) Z. Sun et al. CANCER RESEARCH
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Physiological and pathophysiological roles of NAMPT and NAD metabolism
- (2015) Antje Garten et al. Nature Reviews Endocrinology
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- NAD+ in aging, metabolism, and neurodegeneration
- (2015) E. Verdin SCIENCE
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
- (2014) Valentina Audrito et al. BLOOD
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- MethHC: a database of DNA methylation and gene expression in human cancer
- (2014) Wei-Yun Huang et al. NUCLEIC ACIDS RESEARCH
- NAD+ and sirtuins in aging and disease
- (2014) Shin-ichiro Imai et al. TRENDS IN CELL BIOLOGY
- Influence of Metabolism on Epigenetics and Disease
- (2013) William G. Kaelin et al. CELL
- Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
- (2013) By Fabrizio Montecucco et al. CURRENT DRUG TARGETS
- Histone Deacetylase Sirtuin 1 Deacetylates IRF1 Protein and Programs Dendritic Cells to Control Th17 Protein Differentiation during Autoimmune Inflammation
- (2013) Heeyoung Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
- (2013) Ubaldina Galli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
- (2012) H Yang et al. ONCOGENE
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- NAMPT in Regulated NAD Biosynthesis and its Pivotal Role in Human Metabolism
- (2011) E S. Burgos CURRENT MEDICINAL CHEMISTRY
- Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus
- (2010) J. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phosphorylation-acetylation switch regulates STAT1 signaling
- (2009) O. H. Kramer et al. GENES & DEVELOPMENT
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More